Grade
Accurate reporting
Categories: Testosterone in men >> FDA, regulation and guidelinesAlternatives to testosterone therapySupplements and testosterone boosters
| Source publication date | (content current as of) |
|---|---|
| Reported on Testosterone Science | |
| Outlet type | Legal and regulatory commentary |
| Population | Men |
| Source | Operation Supplement Safety (US Department of Defense) |
| URL | opss.org/article/clomiphene-and-enclomiphene-drugs-not-dietary-supplements (opens in a new tab) |
Specific claim evaluated
Enclomiphene has not been approved by the FDA for any use, clomiphene is not approved for any condition in men, and selling either as a dietary supplement ingredient is illegal.
Primary research supporting or contradicting the claim
Enclomiphene raised testosterone and maintained sperm concentration in phase 3 trials, but these trials did not lead to approval (Kim et al., 2016).
Corrected evidence-based interpretation
The article is correct.
Rationale for grade
The regulatory statements are accurate, and the page correctly warns about products marketed as supplements or research chemicals.
References
- Kim ED, McCullough A, Kaminetsky J. Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men, unlike topical testosterone: restoration instead of replacement. BJU Int. 2016;117(4):677-685. PMID
Supporting excerpt: "Enclomiphene citrate treatment maintained sperm concentrations in the normal range."